<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23009" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hospital-Acquired Infections</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Monegro</surname>
            <given-names>Alberto F.</given-names>
          </name>
          <aff>University of Missouri</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Muppidi</surname>
            <given-names>Vijayadershan</given-names>
          </name>
          <aff>Indiana University health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Regunath</surname>
            <given-names>Hariharan</given-names>
          </name>
          <aff>University of Maryland - Baltimore Washington Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alberto Monegro declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vijayadershan Muppidi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hariharan Regunath declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23009.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hospital-acquired infections (healthcare-associated infections) are nosocomially acquired infections that are not present or incubating at the time of admission to a hospital. These infections include catheter-associated urinary tract infections, central line-associated bloodstream infections, surgical site infections, ventilator-associated pneumonia, hospital-acquired pneumonia, and Clostridium difficile infections. Symptoms that favor an infection include productive cough, shortness of breath, abdominal pain, rebound tenderness, altered mental status, palpitations, suprapubic pain, polyuria, dysuria, and costovertebral angle tenderness. This activity outlines the evaluation and management of hospital-acquired infections and reviews the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the pathophysiology of hospital-acquired infections.</p></list-item><list-item><p>Assess&#x000a0;the laboratory tests used in the evaluation of hospital-acquired infections.</p></list-item><list-item><p>Evaluate&#x000a0;the management of hospital-acquired infections.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among the interprofessional team to prevent infection transmission and enhance the delivery of care for patients affected by hospital-acquired infections.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23009&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23009">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23009.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hospital-acquired infections, or healthcare-associated infections (HAI), are nosocomially acquired infections that are typically absent or might be incubating at admission. These infections are usually acquired after hospitalization and manifest 48 hours after admission to the hospital. The infections are monitored closely by agencies such as the National Healthcare Safety Network (NHSN) of the Center for Disease Control and Prevention (CDC).<xref ref-type="bibr" rid="article-23009.r1">[1]</xref>&#x000a0;This surveillance is done to prevent HAI and improve patient safety. HAI infections include central line-associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI), Hospital-acquired Pneumonia (HAP), Ventilator-associated Pneumonia (VAP), and&#x000a0;<italic toggle="yes">Clostridium difficile</italic>&#x000a0;infections.<xref ref-type="bibr" rid="article-23009.r1">[1]</xref></p>
        <p>For the last few decades, hospitals have taken hospital-acquired infections seriously. Several hospitals have established infection tracking and surveillance systems&#x000a0;and robust prevention strategies to reduce the rate of hospital-acquired infections.<xref ref-type="bibr" rid="article-23009.r2">[2]</xref>&#x000a0;The impact of hospital-acquired infections is seen not just at an individual patient level but also at the community level,&#x000a0;as they have been linked to multidrug-resistant infections. Identifying patients with risk factors for hospital-acquired infections and multidrug-resistant infections is very important in preventing and minimizing these infections.&#x000a0;</p>
        <p>Based on the guidelines from both the Infectious Disease Society of America (IDSA) and the American Thoracic Society (ATS), the definitions of Pneumonia have been changed to better identify patients at risk for multidrug-resistant (MDR) pathogens. This, in turn, is aimed at avoiding the overuse of antibiotics. Healthcare-acquired Pneumonia, or HCAP, which was widely used previously, has been made obsolete. The term Hospital-acquired Pneumonia or HAP has replaced HCAP. Per the IDSA guidelines, Hospital-acquired Pneumonia is defined as "pneumonia that occurs 48 hours or more after admission to the hospital and did not appear to be incubating at the time of admission".<xref ref-type="bibr" rid="article-23009.r3">[3]</xref>&#x000a0;According to IDSA, Ventilator-associated pneumonia or VAP is defined as "pneumonia that develops more than 48 to 72 hours after endotracheal intubation".<xref ref-type="bibr" rid="article-23009.r3">[3]</xref><bold>&#x000a0;&#x000a0;</bold>Both HAP and VAP are associated with poorer outcomes and significant morbidity and mortality worldwide.<xref ref-type="bibr" rid="article-23009.r4">[4]</xref></p>
      </sec>
      <sec id="article-23009.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The risk for hospital-acquired infections depends on the facility's infection control practices, the patient's immune status, and the prevalence of the various pathogens within the community. The risk factors for HAI include immunosuppression, older age, length of stay in the hospital, multiple underlying comorbidities, frequent visits to healthcare facilities, mechanical ventilatory support, recent invasive procedures, indwelling devices, and stay in an intensive care unit (ICU).<xref ref-type="bibr" rid="article-23009.r5">[5]</xref>&#x000a0;Receipt of intravenous antibiotics within the last 90 days is&#x000a0;1 of the major risk factors for developing antimicrobial resistance to multiple drugs.<xref ref-type="bibr" rid="article-23009.r6">[6]</xref>&#x000a0;While hospitalizations play a major role in the management of acute illnesses, they also enhance the risk of susceptible patients to multiple nosocomial and often antimicrobial-resistant pathogens. These pathogens can be acquired from other patients, hospital staff, or the hospital facility. The risk is higher among patients in ICU. A point prevalence study that included 231,459 patients across 947 hospitals concluded that about 19.5% of patients in ICU had at least&#x000a0;1 HAI.<xref ref-type="bibr" rid="article-23009.r7">[7]</xref>&#x000a0; &#x000a0;</p>
        <p>Clostridium difficile is the organism&#x000a0;that causes Clostridium difficile colitis. Common organisms for CLABSI are candida spp (adult ICU), Enterobacteriaceae (adult wards, pediatric ICU and wards, and oncology wards), and staph aureus.<xref ref-type="bibr" rid="article-23009.r8">[8]</xref>&#x000a0;Common pathogens known to cause CAUTI are Enterococcus, staphylococcus aureus, Pseudomonas, Proteus, Klebsiella, and Candida.<xref ref-type="bibr" rid="article-23009.r9">[9]</xref><bold>&#x000a0;</bold>According to the National Healthcare Safety Network, the common causative organisms for SSI include (in descending order) staph aureus, coagulase-negative staphylococcus, Enterococcus, E. coli, Pseudomonas aeruginosa, Enterobacter, Klebsiella pneumoniae.<xref ref-type="bibr" rid="article-23009.r10">[10]</xref>&#x000a0;The most common pathogens for HAP and VAP are staph aureus and Pseudomonas aeruginosa, while E. coli and Klebsiella pneumoniae can be seen in higher proportions among pediatric populations.<xref ref-type="bibr" rid="article-23009.r11">[11]</xref></p>
      </sec>
      <sec id="article-23009.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>2014, the CDC published a multistate point prevalence survey of healthcare-associated infections involving 11,282 patients from 183 US hospitals.<xref ref-type="bibr" rid="article-23009.r12">[12]</xref>&#x000a0;According to this report, about 4% of hospitalized patients suffer from at least 1 of the HAIs.&#x000a0;In absolute numbers, in 2011, an estimated 648,000 hospitalized patients suffered from 721,800 infections.<xref ref-type="bibr" rid="article-23009.r12">[12]</xref>&#x000a0;The dominant infections (in descending order) include Pneumonia (21.8%), surgical site infections (21.8%), gastrointestinal infections (17.1%), urinary tract infections or UTIs (12.9%), and primary bloodstream infections (9.9%, and include Catheter-associated bloodstream infections).<xref ref-type="bibr" rid="article-23009.r12">[12]</xref>&#x000a0;Among the pathogens causing HAI,&#x000a0;<italic toggle="yes">C. difficile</italic>&#x000a0;(12.1%) is the leading pathogen and is closely followed by&#x000a0;<italic toggle="yes">Staphylococcus aureus</italic>&#x000a0;(10.7%),&#x000a0;<italic toggle="yes">Klebsiella</italic>&#x000a0;(9.9%), and&#x000a0;<italic toggle="yes">Escherichia coli</italic>&#x000a0;(9.3%).<xref ref-type="bibr" rid="article-23009.r12">[12]</xref>&#x000a0;Skin and surgical site infections are usually caused by Staphylococcus aureus and sometimes include Methicillin-resistant staphylococcus aureus (MRSA). The SENIC study (Study on Efficacy of Nosocomial Infection Control) highlighted the possibility of reducing infections by a third by combining infection tracking and infection control programs.<xref ref-type="bibr" rid="article-23009.r13">[13]</xref>&#x000a0;Due to greater awareness and robust preventative measures undertaken in hospital settings, there has been some reduction in certain HAIs. Implementing robust infection surveillance and prevention practices has resulted in some success in preventing HAI. According to the CDC, the rates of CLABSI decreased by 46% between 2008 and 2013.<xref ref-type="bibr" rid="article-23009.r1">[1]</xref></p>
      </sec>
      <sec id="article-23009.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Transmission of pathogens in a healthcare environment is complex and can occur through direct contact with healthcare workers or the surrounding contaminated environment.&#x000a0;Risk factors for the development of&#x000a0;<italic toggle="yes">Clostridium difficile</italic>&#x000a0;infections are well known. These include recent antibiotic use, gastric acid suppressants, nonselective non-steroidal anti-inflammatory drugs (NSAIDs), and some comorbidities.<xref ref-type="bibr" rid="article-23009.r14">[14]</xref>&#x000a0;Risk factors for SSI include both patient factors such as age, diabetes, obesity, nutritional status, colonization, co-existing infections, and operative factors such as duration of the procedure, skin antisepsis, surgical technique, antimicrobial prophylaxis.<xref ref-type="bibr" rid="article-23009.r10">[10]</xref>&#x000a0;Some pathogens possess a tendency to colonize in areas with warmth and moisture. These areas are typically located in the inguinal and perineal region, axilla, and trunk. Certain bacteria and fungi thrive in such environments.&#x000a0;</p>
        <p>Some of the proposed mechanisms of CAUTI are intraluminal colonization, retrograde intraluminal ascent, extraluminal peri urethral spread, and biofilms adherent to the urinary catheters.<xref ref-type="bibr" rid="article-23009.r15">[15]</xref>&#x000a0;Some organisms, such as&#x000a0;<italic toggle="yes">Pseudomonas</italic>&#x000a0;and Proteus species<italic toggle="yes">,&#x000a0;</italic>can form tough biofilms around catheters. Sometimes, these pathogens produce enzymes that inactivate the antimicrobial agents, making it harder to treat these infections.<xref ref-type="bibr" rid="article-23009.r16">[16]</xref>&#x000a0;Mechanisms of infection in central line-associated bloodstream infections include colonization, biofilm formation, and extraluminal migration. The femoral site is associated with an increased risk of infections and should be avoided if possible.<xref ref-type="bibr" rid="article-23009.r17">[17]</xref>&#x000a0;Staphylococcus aureus and Staphylococcus epidermidis are common organisms associated with catheter biofilm formation.<xref ref-type="bibr" rid="article-23009.r18">[18]</xref>&#x000a0;Coagulase-negative staphylococci (CoNS), commonly found in skin flora, is a common cause of colonization of central lines and, thereby, central line-associated bloodstream infections.&#x000a0;</p>
        <p>Multidrug-resistant (MDR) pathogens are also a significant cause of hospital infections, particularly in the intensive care unit. Infections with MDR organisms are associated with increased length of stay (LOS), mortality indicators, and care costs.<xref ref-type="bibr" rid="article-23009.r19">[19]</xref>&#x000a0;MDR pathogens are resistant to at least&#x000a0;1 antibiotic from&#x000a0;3 different classes or with different mechanisms of action.<xref ref-type="bibr" rid="article-23009.r20">[20]</xref>&#x000a0;MDR organisms are often suspected of HAP and VAP. The use of intravenous antibiotics within the past 90 days is an important risk factor for MDR infections.<xref ref-type="bibr" rid="article-23009.r3">[3]</xref><bold>&#x000a0;</bold>Other risk factors for MDR VAP include the presence of septic shock at the time of VAP onset and duration of hospitalization, Acute respiratory distress syndrome, and acute renal replacement therapy before the onset of VAP.<xref ref-type="bibr" rid="article-23009.r3">[3]</xref></p>
      </sec>
      <sec id="article-23009.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Pharmacokinetics and pharmacodynamics change during an acute illness, especially during sepsis. For a given drug, the volume of distribution varies depending on the phase of the illness or recovery. This is an important concept and must be considered when determining dosing medication dosings, especially for drugs like aminoglycosides and beta-lactams. Another important determinant of the dosing of renal-excreted medications is the estimated glomerular filtration rate (eGFR), which may be impaired in sepsis. The IDSA and ATS recommend selecting antibiotic dosing based on pharmacokinetics and pharmacodynamics for critically ill patients with ventilator-associated Pneumonia.<xref ref-type="bibr" rid="article-23009.r21">[21]</xref>&#x000a0;An antibiotic's efficacy may be concentration-dependent (fluoroquinolones and aminoglycosides), time-dependent (beta-lactams), or a combination of both (Vancomycin). Time-dependent drugs are administered as extended infusions to maintain concentrations within&#x000a0;4 times the minimum inhibitory concentrations. In contrast, concentration-dependent drugs are dosed targeting&#x000a0;1 high peak (with a 1-time high dose) or multiple peaks with intermittent dosing.</p>
      </sec>
      <sec id="article-23009.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Obtaining thorough details in history and a comprehensive physical examination is important in determining whether the infection was acquired before admission or is a hospital-acquired infection. Important pieces of history, such as subjective fever, chills, and night sweats, may indicate that the infection was not hospital-acquired. Common infectious symptoms include fever, chills, altered mental status, productive cough, shortness of breath, palpitations, abdominal pain, flank pain, suprapubic pain, polyuria, dysuria, and diarrhea. Vital signs can reflect signs of systemic inflammatory response or sepsis. These include hypothermia or hyperthermia, tachypnea, tachycardia, and hypotension. Examination of external devices such as tracheostomies, endotracheal tubes, foley catheters, intravascular lines, insulin pumps, and pacemakers/ defibrillators is essential. Supplementing the examination of external devices is the information on the location and placement of the device (duration and setting).</p>
        <p>Central lines placed hastily during emergencies need to be re-evaluated and possibly replaced within 24 to 48 hours, especially in the context of aseptic conditions during line placement or a new fever during hospitalization. Central venous catheters are considered the primary source of hospital-acquired bloodstream infections. The other sources of bloodstream infections are catheter-associated urinary tract infections and ventilator-associated Pneumonia. The surgical sites and breaches in skin integrity should be examined daily for any signs of evolving infection. Thorough and serial examinations go a long way in identifying brewing infections in early phases, containing the infections, and minimizing complications. Careful examination of the abdomen and stool samples is often needed to evaluate clostridium difficile infection.</p>
      </sec>
      <sec id="article-23009.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory testing complements the history and clinical examination in elucidating the possible source of infection and revealing evidence of organ dysfunction. Serum levels of lactic acid, liver transaminases, prothrombin time, blood urea nitrogen (BUN), and serum creatinine can support clinical findings of hypoperfusion. Other important lab findings include low or elevated white cell counts, elevated bands, thrombocytopenia, hypoglycemia, hyperglycemia, and reduced mixed venous blood saturation. Obtaining samples for cultures before the initiation of antibiotics is vital in the early identification of the pathogen and the antimicrobial susceptibility pattern. Pathogen and antibiotic susceptibility help narrow the range from broad-spectrum antibiotics to specific agents targeted toward the pathogens. Investigations that do not alter clinical decision-making or the clinical course are not usually recommended. Suppose the pretest probability is high for an HAI such as ventilator-associated pneumonia/ VAP. In that case, tests such as C-reactive protein (CRP) and procalcitonin are considered ancillary and not indicated. For patients with HAP/ VAP, recent IDSA guidelines recommend noninvasive sampling with tracheal aspirates as they have been shown to have non-inferior yield compared to invasive samplings such as quantitative tracheal lavage or bronchoscopy.<xref ref-type="bibr" rid="article-23009.r21">[21]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23009.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management of hospital-acquired infections follows standard goal-directed therapy of sepsis, antibiotics, fluid resuscitation, and close monitoring for organ dysfunction. Serial assessments of the clinical and hemodynamic responses should follow fluid resuscitation. The selection and timing of initiation of antibiotics are critical. Empiric antibiotics should be selected based on risk factors for MDR pathogens and the patient's clinical stability. Antibiotics should be started early, within an hour if possible. If central line-associated bloodstream infection is suspected, two sets of blood cultures, 1 from a peripheral venous site and the other from the central venous catheter site, should be obtained before initiating antibiotic therapy.&#x000a0;In case of hypotension, hypoperfusion, or organ dysfunction, the catheter must be removed without delay, and the tip should be sent for culture.</p>
        <p>When suspecting catheter-associated urinary tract infections, the old catheter must be removed, and a urine sample from the newly placed catheter must be obtained, preferably before initiating antibiotics. These measures have been shown to enhance the yield of microbiological specimens. As part of the standard precautions, all catheters (including central lines and urinary catheters) should be removed if they are no longer indicated.<xref ref-type="bibr" rid="article-23009.r9">[9]</xref>&#x000a0;For catheter-associated UTIs,&#x000a0;7 days of antibiotics are typically recommended. However, in case of a delayed response or bacteremia, the antibiotic course could be extended to 10 - 14 days. Reducing usage, minimizing dwelling, using antimicrobial catheters, and using antibiotic prophylaxis in certain situations help prevent CAUTI.<xref ref-type="bibr" rid="article-23009.r9">[9]</xref>&#x000a0;The usual duration of the antibiotic regimen in HAP or VAP is&#x000a0;7 days unless a longer duration is clinically indicated.<xref ref-type="bibr" rid="article-23009.r21">[21]</xref>&#x000a0;Antibiotic regimens typically include activity against staph aureus and Pseudomonas aeruginosa.<xref ref-type="bibr" rid="article-23009.r3">[3]</xref>&#x000a0;MDR pathogens need different antibiotics than the usual antibiotics.&#x000a0;</p>
        <p>CLABSI incidence has decreased in the US over the years due to increasing awareness and implementation of evidence-based preventive strategies such as aseptic precautions at the time of insertion, removal of unnecessary catheters, chlorhexidine baths, antimicrobial dressings, and catheter lock solutions.<xref ref-type="bibr" rid="article-23009.r22">[22]</xref>&#x000a0;The antibiotic duration for central line-associated bloodstream infections depends on whether the infection is complicated or uncomplicated and whether the catheter is retained or removed. Determinants of complicated central line-associated bloodstream infections include suppurative thrombophlebitis, osteomyelitis, endocarditis, persistent positive cultures after 72 hours, and active malignancy or immunosuppression.<xref ref-type="bibr" rid="article-23009.r23">[23]</xref>&#x000a0;For Clostridium difficile infections, oral vancomycin is usually the drug of choice, and sometimes, the underlying antibiotic regimen for primary infection might need to be altered. Metronidazole is an alternative medication. Newer medications include fidaxomicin.<xref ref-type="bibr" rid="article-23009.r24">[24]</xref>&#x000a0;Other options, such as teicoplanin, among other antibiotics, are being explored.<xref ref-type="bibr" rid="article-23009.r24">[24]</xref>&#x000a0;Fecal microbiota transplantation is reserved for severe refractory cases.</p>
        <p>Proper hand hygiene and appropriate infection prevention strategies must be followed postoperatively caring for surgical sites. Also, antibiotic prophylaxis and skin decontamination are important factors in preventing SSI.<xref ref-type="bibr" rid="article-23009.r10">[10]</xref>&#x000a0;Antibiotics to cover common pathogens in case of surgical site infections need to be employed early and later adjusted per reports from cultures. Antibiotics to cover staphylococcus aureus and other organisms such as Pseudomonas are usually initiated, depending upon the clinical scenario. Sometimes, antibiotics with activity against MDR pathogens such as MRSA and carbapenemase-producing Enterobacteria must be considered.<bold><xref ref-type="bibr" rid="article-23009.r10">[10]</xref>&#x000a0;</bold>Universal standard (infection control) measures, such as handwashing with soap and water or using alcohol-based disinfectant before and after each patient visit, are vital in reducing transmission rates of MDR pathogens. In a study, gloves and gowns did not prevent contamination and conclusively did not seem enough to prevent the spread of infections.<xref ref-type="bibr" rid="article-23009.r25">[25]</xref></p>
      </sec>
      <sec id="article-23009.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnosis for hospital-acquired infections include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial sepsis</p>
          </list-item>
          <list-item>
            <p>Clostridium Difficile Colitis</p>
          </list-item>
          <list-item>
            <p>Pseudomonas</p>
          </list-item>
          <list-item>
            <p>Acinetobacter</p>
          </list-item>
          <list-item>
            <p>Enterococcal infections</p>
          </list-item>
          <list-item>
            <p>MRSA</p>
          </list-item>
          <list-item>
            <p>Legionella</p>
          </list-item>
          <list-item>
            <p>Viral hepatitis</p>
          </list-item>
          <list-item>
            <p>HIV</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23009.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of hospital-acquired infections include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Endocarditis</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
          <list-item>
            <p>ARDs</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23009.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Over the years, various preventive strategies have been employed to reduce hospital-acquired infections. The major principles of prevention include hand hygiene, contact precautions when indicated, antibiotic stewardship to avoid the rise of MDR organisms, appropriate antimicrobial prophylaxis, particularly for surgeries, patient positioning, subglottic suction to avoid aspiration, strict asepsis when placing a central line, limiting unnecessary use of external devices, removal of catheters as soon as no longer indicated, and decontamination with chlorhexidine bathing for patients in the intensive care unit.</p>
      </sec>
      <sec id="article-23009.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>
<bold>An Interprofessional Approach to Healthcare-Associated Infections</bold>
</p>
        <p>Healthcare-associated infections have very high morbidity and mortality, costing the healthcare system billions of dollars each year. Over the years, many guidelines have been developed for monitoring, performing, and monitoring central lines and isolation of infected patients. Only a concerted effort by all healthcare teams can have an impact. The primary strategy employed in hospitals is to prevent the transmission of infectious agents among patients and healthcare providers. Nurses play a vital role in prevention as they are often the first to encounter infected patients. Washing hands and ensuring everyone follows the established rules for infection prevention are key. Several Category 1A recommendations include educating healthcare workers about infection control procedures, hand washing, using aseptic techniques when performing invasive procedures, and securing catheters.<xref ref-type="bibr" rid="article-23009.r1">[1]</xref>&#x000a0;Further, disinfecting hospital rooms and decreasing environmental contamination is also encouraged. Finally, with a rise in antibiotic resistance organisms, a hospital committee consisting of a pharmacist should be established to ensure that the empirical use of antibiotics is not routine and that certain antibiotics cannot be used without prior approval from the committee.</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>Healthcare-associated infections increase the length of stay, healthcare costs, and mortality. Each year, the top 5 healthcare-associated infections cost about $9.8 billion, with surgical site infections leading the pack.<xref ref-type="bibr" rid="article-23009.r26">[26]</xref>&#x000a0;Healthcare costs occur in every medical and surgical department, including the ICU. However, with more awareness and better guidelines, sepsis and central line infections appear to be declining. Most hospitals have established best practices for inserting central lines and wound care. All members in all disciplines of the interprofessional healthcare team must be involved in this process.<xref ref-type="bibr" rid="article-23009.r1">[1]</xref></p>
      </sec>
      <sec id="article-23009.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23009&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23009">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/hospital-acquired-infections/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23009">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23009/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23009">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23009.s15">
        <title>References</title>
        <ref id="article-23009.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boev</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kiss</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hospital-Acquired Infections: Current Trends and Prevention.</article-title>
            <source>Crit Care Nurs Clin North Am</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-65</page-range>
            <pub-id pub-id-type="pmid">28160957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Habboush</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yarrarapu</surname>
                <given-names>SNS</given-names>
              </name>
              <name>
                <surname>Guzman</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <chapter-title>Infection Control</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">30085559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalil</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Metersky</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Klompas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muscedere</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carratal&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El Solh</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ewig</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fey</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>File</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Waterer</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Cruse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>e61</fpage>
            <page-range>e61-e111</page-range>
            <pub-id pub-id-type="pmid">27418577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cill&#x000f3;niz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Domined&#x000f2;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>656</fpage>
            <page-range>656-662</page-range>
            <pub-id pub-id-type="pmid">31567412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sydnor</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Perl</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Hospital epidemiology and infection control in acute-care settings.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>141</fpage>
            <page-range>141-73</page-range>
            <pub-id pub-id-type="pmid">21233510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metersky</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Kalil</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>New guidelines for nosocomial pneumonia.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2017</year>
            <month>May</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-217</page-range>
            <pub-id pub-id-type="pmid">28198727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stiller</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schr&#x000f6;der</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gropmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwab</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Behnke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geffers</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sunder</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Holzhausen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gastmeier</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>ICU ward design and nosocomial infection rates: a cross-sectional study in Germany.</article-title>
            <source>J Hosp Infect</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-75</page-range>
            <pub-id pub-id-type="pmid">27884473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Novosad</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Fike</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dudeck</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Allen-Bridson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Edens</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sinkowitz-Cochran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kuhar</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pathogens causing central-line-associated bloodstream infections in acute-care hospitals-United States, 2011-2017.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>313</fpage>
            <page-range>313-319</page-range>
            <pub-id pub-id-type="pmid">31915083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flores-Mireles</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hreha</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Hunstad</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.</article-title>
            <source>Top Spinal Cord Inj Rehabil</source>
            <year>2019</year>
            <season>Summer</season>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-240</page-range>
            <pub-id pub-id-type="pmid">31548790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Young</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Khadaroo</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Surgical site infections.</article-title>
            <source>Surg Clin North Am</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>1245</fpage>
            <page-range>1245-64</page-range>
            <pub-id pub-id-type="pmid">25440122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Babcock</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Zack</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Garrison</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Trovillion</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kollef</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>853</fpage>
            <page-range>853-8</page-range>
            <pub-id pub-id-type="pmid">14649775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magill</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Bamberg</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Beldavs</surname>
                <given-names>ZG</given-names>
              </name>
              <name>
                <surname>Dumyati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kainer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lynfield</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maloney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McAllister-Hollod</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nadle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Fridkin</surname>
                <given-names>SK</given-names>
              </name>
              <collab>Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team</collab>
            </person-group>
            <article-title>Multistate point-prevalence survey of health care-associated infections.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Mar</month>
            <day>27</day>
            <volume>370</volume>
            <issue>13</issue>
            <fpage>1198</fpage>
            <page-range>1198-208</page-range>
            <pub-id pub-id-type="pmid">24670166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hughes</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future.</article-title>
            <source>Chemotherapy</source>
            <year>1988</year>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>553</fpage>
            <page-range>553-61</page-range>
            <pub-id pub-id-type="pmid">3243099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eze</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Balsells</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kyaw</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for <italic>Clostridium difficile</italic> infections - an overview of the evidence base and challenges in data synthesis.</article-title>
            <source>J Glob Health</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>010417</fpage>
            <pub-id pub-id-type="pmid">28607673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nickel</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Costerton</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Bacterial biofilms and catheters: A key to understanding bacterial strategies in catheter-associated urinary tract infection.</article-title>
            <source>Can J Infect Dis</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>261</fpage>
            <page-range>261-7</page-range>
            <pub-id pub-id-type="pmid">22416201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>del Pozo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The challenge of treating biofilm-associated bacterial infections.</article-title>
            <source>Clin Pharmacol Ther</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>204</fpage>
            <page-range>204-9</page-range>
            <pub-id pub-id-type="pmid">17538551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bell</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Prevention of Central Line-Associated Bloodstream Infections.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>551</fpage>
            <page-range>551-559</page-range>
            <pub-id pub-id-type="pmid">28687213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khawaja</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Central Line Catheters and Associated Complications: A Review.</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>May</month>
            <day>22</day>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>e4717</fpage>
            <pub-id pub-id-type="pmid">31355077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serra-Burriel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Keys</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campillo-Artero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agodi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barchitta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gikas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Casasnovas</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2020</year>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>e0227139</fpage>
            <pub-id pub-id-type="pmid">31923281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magiorakos</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Srinivasan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Carmeli</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Falagas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Giske</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Harbarth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hindler</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Kahlmeter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Olsson-Liljequist</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Stelling</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Struelens</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Vatopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Monnet</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-81</page-range>
            <pub-id pub-id-type="pmid">21793988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalil</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Metersky</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Klompas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Muscedere</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carratal&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El Solh</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ewig</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fey</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>File</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Waterer</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Cruse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.</article-title>
            <source>Clin Infect Dis</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>575</fpage>
            <page-range>575-82</page-range>
            <pub-id pub-id-type="pmid">27521441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Maragakis</surname>
                <given-names>LL</given-names>
              </name>
            </person-group>
            <article-title>Central line-associated bloodstream infection prevention.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>412</fpage>
            <page-range>412-22</page-range>
            <pub-id pub-id-type="pmid">22766647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mermel</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Allon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bouza</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Craven</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Raad</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Rijnders</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Sherertz</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2009</year>
            <month>Jul</month>
            <day>01</day>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-45</page-range>
            <pub-id pub-id-type="pmid">19489710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Momani</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Abughanimeh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Boonpheng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review.</article-title>
            <source>Cureus</source>
            <year>2018</year>
            <month>Jun</month>
            <day>11</day>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>e2778</fpage>
            <pub-id pub-id-type="pmid">30112254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Furuya</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Impact of Universal Contact Precautions on Rates of Multidrug-Resistant Organisms in ICUs: A Comparative Effectiveness Study.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2018</year>
            <month>May</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>534</fpage>
            <page-range>534-540</page-range>
            <pub-id pub-id-type="pmid">29562944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23009.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danna</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Hospital Costs Associated with Sepsis Compared with Other Medical Conditions.</article-title>
            <source>Crit Care Nurs Clin North Am</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-398</page-range>
            <pub-id pub-id-type="pmid">30098742</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
